Board of Directors
Matthew Emmens
Chairman
Matthew was appointed Chairman on June 18, 2008 and has been a member of the Board since March 12, 2003. He is also a member of the Nomination Committee. He was the Company’s Chief Executive Officer from March 2003 to June 2008.
Matthew brings to the Board his operational knowledge of Shire and his wealth of international sales, marketing, integration and operational experience in the pharmaceutical sector. Matthew is a Director of Vertex Pharmaceuticals Inc. He served as Chairman, CEO and President of Vertex Pharmaceuticals Inc. from 2009 until early 2012 and is a former Director of Incyte Corporation.

Flemming Ornskov, MD
Chief Executive Officer
Flemming assumed the position of Chief Executive Officer on April 30, 2013. He is a member of the Board of Directors and is also a member of the Company’s Leadership Team.

Graham Hetherington
Chief Financial Officer
Graham has been the Chief Financial Officer and a member of the Board since July 1, 2008. He is also a member of the Leadership Team.

David Kappler
Deputy Chairman and Senior Independent Non-Executive Director
David has been a member of the Board since April 5, 2004. He was appointed Senior Independent Non-Executive Director in July 2007 and Deputy Chairman in June 2008. He is also Chairman of the Nomination Committee and a member of the Audit, Compliance & Risk Committee.

David Stout
Non-Executive Director
David was appointed to the Board on October 31, 2009 and is a member of the Audit, Compliance & Risk Committee and of the Remuneration Committee.

William Burns
Non-Executive Director
William was appointed to the Board on March 15, 2010 and is a member of the Remuneration Committee, the Nomination Committee and of the Science & Technology Committee.

Dr. David Ginsburg
Non-Executive Director
David was appointed to the Board on June 16, 2010 and is Chairman of the Science & Technology Committee.

Anne Minto
Non-Executive Director
Anne was appointed to the Board on June 16, 2010 and is Chairman of the Remuneration Committee and a member of the Nomination Committee.

Susan Kilsby
Non-Executive Director
Susan was appointed to the Board on September 1, 2011 and is Chairman of the Audit, Compliance & Risk Committee.

Dr. Steven Gillis
Non-Executive Director
Steven was appointed to the Board on October 1, 2012 and is a member of the Science & Technology Committee and of the Remuneration Committee.

Did you know...
We have developed a
version of this web site
that is suitable for your
portable device.
Our global reach
Our products are marketed in over 50 countries worldwide, and we now have offices in 29 countries. View our interactive map, and learn more
about our global reach.
